Vericel (VCEL) Short Interest Ratio & Short Volume → Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) (Ad) Free VCEL Stock Alerts $48.52 +0.42 (+0.87%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vericel Short Interest DataCurrent Short Volume4,480,000 sharesPrevious Short Volume4,530,000 sharesChange Vs. Previous Month-1.10%Dollar Volume Sold Short$205.50 millionShort Interest Ratio / Days to Cover10.3Last Record DateApril 30, 2024Outstanding Shares48,600,000 sharesPercentage of Shares Shorted9.22%Today's Trading Volume294,288 sharesAverage Trading Volume519,343 sharesToday's Volume Vs. Average57% Short Selling Vericel ? Sign up to receive the latest short interest report for Vericel and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVCEL Short Interest Over TimeVCEL Days to Cover Over TimeVCEL Percentage of Float Shorted Over Time Ad InvestorPlaceDoes this chart look familiar?Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here. Vericel Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,480,000 shares $205.50 million -1.1%N/A10.3 $45.87 4/15/20244,530,000 shares $220.61 million +3.2%N/A10.1 $48.70 3/31/20244,390,000 shares $228.37 million +85.2%N/A8.2 $52.02 3/15/20242,370,000 shares $104.90 million +4.4%N/A4.1 $44.26 2/29/20242,270,000 shares $103.69 million +18.9%N/A4.1 $45.68 2/15/20241,910,000 shares $94.30 million +10.4%N/A3.6 $49.37 Get the Latest News and Ratings for VCEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vericel and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,730,000 shares $74.36 million -28.2%N/A3.4 $42.98 1/15/20242,410,000 shares $92.16 million -58.8%N/A5 $38.24 12/31/20235,850,000 shares $208.32 million -0.5%N/A13.9 $35.61 12/15/20235,880,000 shares $216.44 million -3.1%N/A17.5 $36.81 11/30/20236,070,000 shares $215.73 million +1.0%N/A18.8 $35.54 11/15/20236,010,000 shares $216.66 million No ChangeN/A18.6 $36.05 10/31/20236,010,000 shares $211.43 million +1.5%N/A18.6 $35.18 10/15/20235,920,000 shares $186.84 million +5.9%N/A16.4 $31.56 9/30/20235,590,000 shares $187.38 million +3.7%12.4%15.7 $33.52 9/15/20235,390,000 shares $184.82 million +1.7%12.0%14.9 $34.29 8/31/20235,300,000 shares $174.00 million -1.1%11.8%14 $32.83 8/15/20235,360,000 shares $171.73 million -6.5%11.9%14.3 $32.04 7/31/20235,730,000 shares $205.82 million +2.9%12.7%15.5 $35.92 7/15/20235,570,000 shares $217.34 million +0.9%12.4%17.3 $39.02 6/30/20235,520,000 shares $207.39 million -0.9%12.3%17.7 $37.57 6/15/20235,570,000 shares $191.22 million -0.5%12.4%18.7 $34.33 5/31/20235,600,000 shares $179.87 million +4.1%12.5%19.1 $32.12 5/15/20235,380,000 shares $181.58 million -2.2%12.0%17.1 $33.75 4/30/20235,500,000 shares $173.31 million -0.9%12.3%17.1 $31.51 4/15/20235,550,000 shares $165.56 million -2.3%12.5%16.9 $29.83 3/31/20235,680,000 shares $166.54 million -4.1%12.8%15.1 $29.32 3/15/20235,920,000 shares $182.99 million +0.9%N/A14.1 $30.91 2/28/20235,870,000 shares $178.51 million +1.9%N/A13.7 $30.41 2/15/20235,760,000 shares $170.09 million -1.2%N/A13.9 $29.53 1/31/20235,830,000 shares $160.15 million -3.5%N/A12.3 $27.47 1/15/20236,040,000 shares $170.39 million -1.2%N/A12.5 $28.21 12/30/20226,110,000 shares $160.94 million -1.6%N/A12.6 $26.34 12/15/20226,210,000 shares $149.23 million -2.7%N/A13.3 $24.03 11/30/20226,380,000 shares $145.66 million +1.8%N/A13.6 $22.83 11/15/20226,270,000 shares $145.97 million -7.7%N/A12.7 $23.28 10/31/20226,790,000 shares $182.52 million -4.2%N/A14.3 $26.88 10/15/20227,090,000 shares $171.93 million -3.9%N/A16 $24.25 9/30/20227,380,000 shares $171.22 million -7.4%N/A17.1 $23.20 9/15/20227,970,000 shares $208.42 million +1.7%N/A18.4 $26.15This 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here VCEL Short Interest - Frequently Asked Questions What is Vericel's current short interest? Short interest is the volume of Vericel shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,480,000 shares of VCEL short. Learn More on Vericel's current short interest. What is a good short interest ratio for Vericel? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VCEL shares currently have a short interest ratio of 10.0. Learn More on Vericel's short interest ratio. Is Vericel's short interest increasing or decreasing? Vericel saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 4,480,000 shares, a drop of 1.1% from the previous total of 4,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Vericel's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Vericel: Denali Therapeutics Inc. (8.16%), Kymera Therapeutics, Inc. (16.15%), Twist Bioscience Co. (20.49%), Apogee Therapeutics, Inc. (14.00%), Sana Biotechnology, Inc. (20.85%), Recursion Pharmaceuticals, Inc. (24.98%), Ginkgo Bioworks Holdings, Inc. (20.84%), Arcellx, Inc. (8.89%), Beam Therapeutics Inc. (17.03%), Fusion Pharmaceuticals Inc. (4.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Vericel stock? Short selling VCEL is an investing strategy that aims to generate trading profit from Vericel as its price is falling. VCEL shares are trading up $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vericel? A short squeeze for Vericel occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VCEL, which in turn drives the price of the stock up even further. How often is Vericel's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VCEL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Denali Therapeutics Short Squeeze Kymera Therapeutics Short Squeeze Twist Bioscience Short Squeeze Apogee Therapeutics Short Squeeze Sana Biotechnology Short Squeeze Recursion Pharmaceuticals Short Squeeze Ginkgo Bioworks Short Squeeze Arcellx Short Squeeze Beam Therapeutics Short Squeeze Fusion Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VCEL) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 Media